Artiva Biotherapeutics, Inc.'s total assets for Q1 2026 were $105.95M, a decrease of -19.08% from the previous quarter. ARTV total liabilities were $18.11M for the fiscal quarter, a -13.65% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.